Oligonucleotide therapeutics have attracted much attention recently. They represent an up-and-coming class of therapeutic options that can lead to major advances in the treatment or cure of diseases, holding great potential for further development in human medicine.

Access the infographic to learn about:

  • Common types of oligonucleotide therapeutics
  • Milestones in oligonucleotide therapeutics
  • Main differences between ASOs and siRNAs
  • Oligonucleotide research areas for therapeutic development
  • Phosphoramidites in the development of oligonucleotide therapeutics
  • Future of oligonucleotide therapeutics


What type of oligos are you working on for oligo therapeutics development? (check all that apply)*

 Antisense oligos (ASOs)
 Guide RNAs (gRNAs)
 Small activating RNAs (saRNAs)
 Small interfering RNAs (siRNAs)

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.